rs145160426
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 1P and 0B. PP3
The NM_004320.6(ATP2A1):c.840C>A(p.Asn280Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,614,032 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N280S) has been classified as Likely benign.
Frequency
Consequence
NM_004320.6 missense
Scores
Clinical Significance
Conservation
Publications
- Brody myopathyInheritance: AR, AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ATP2A1 | NM_004320.6 | c.840C>A | p.Asn280Lys | missense_variant | Exon 8 of 23 | ENST00000395503.9 | NP_004311.1 | |
| ATP2A1 | NM_173201.5 | c.840C>A | p.Asn280Lys | missense_variant | Exon 8 of 22 | NP_775293.1 | ||
| ATP2A1 | NM_001286075.2 | c.465C>A | p.Asn155Lys | missense_variant | Exon 6 of 21 | NP_001273004.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ATP2A1 | ENST00000395503.9 | c.840C>A | p.Asn280Lys | missense_variant | Exon 8 of 23 | 1 | NM_004320.6 | ENSP00000378879.5 | ||
| ATP2A1 | ENST00000357084.7 | c.840C>A | p.Asn280Lys | missense_variant | Exon 8 of 22 | 2 | ENSP00000349595.3 | |||
| ATP2A1 | ENST00000536376.5 | c.465C>A | p.Asn155Lys | missense_variant | Exon 6 of 21 | 2 | ENSP00000443101.1 | |||
| ATP2A1 | ENST00000564732.1 | n.-31C>A | upstream_gene_variant | 5 | ENSP00000457357.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152158Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000119 AC: 3AN: 251224 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461874Hom.: 0 Cov.: 35 AF XY: 0.00000138 AC XY: 1AN XY: 727236 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152158Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74320 show subpopulations
ClinVar
Submissions by phenotype
Brody myopathy Uncertain:1
Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with ATP2A1-related conditions. This variant is present in population databases (rs145160426, gnomAD 0.006%). This sequence change replaces asparagine, which is neutral and polar, with lysine, which is basic and polar, at codon 280 of the ATP2A1 protein (p.Asn280Lys). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at